Vetigenics

Vetigenics is a clinical-stage animal health biotechnology company developing antibody therapeutics for pets. Their proprietary CANIBODY technology enables faster and more cost-effective antibody development, targeting unmet needs in treating canine cancers and other pet diseases like autoimmune disorders, obesity, and allergies.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $6M

Date: 03-Feb-2025

Investors:

Markets: Animal Health, Biotech, Therapeutics

HQ: Philadelphia, Pennsylvania, United States

Founded: 2017

Website: http://www.vetigenics.com/

LinkedIn: https://www.linkedin.com/company/vetigenics

Twitter:

Instagram: